HK1125624A1 - Mutilin derivatives adn their use as pharmaceutical - Google Patents

Mutilin derivatives adn their use as pharmaceutical

Info

Publication number
HK1125624A1
HK1125624A1 HK09104021.6A HK09104021A HK1125624A1 HK 1125624 A1 HK1125624 A1 HK 1125624A1 HK 09104021 A HK09104021 A HK 09104021A HK 1125624 A1 HK1125624 A1 HK 1125624A1
Authority
HK
Hong Kong
Prior art keywords
mutilins
phenylsulfanyl
acetyl
alkyl
adn
Prior art date
Application number
HK09104021.6A
Other languages
English (en)
Chinese (zh)
Inventor
.瑟林
.阿舍爾
.鮑爾科納
.黑爾梅爾
.諾瓦克
Original Assignee
納布裡瓦治療股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 納布裡瓦治療股份公司 filed Critical 納布裡瓦治療股份公司
Publication of HK1125624A1 publication Critical patent/HK1125624A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/22Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK09104021.6A 2006-01-16 2009-04-30 Mutilin derivatives adn their use as pharmaceutical HK1125624A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06000827A EP1808431A1 (de) 2006-01-16 2006-01-16 Mutilin Derivate und ihre Verwendung als Arzneimittel
PCT/AT2007/000009 WO2007079515A1 (en) 2006-01-16 2007-01-11 Mutilin derivatives and their use as pharmaceutical

Publications (1)

Publication Number Publication Date
HK1125624A1 true HK1125624A1 (en) 2009-08-14

Family

ID=36127922

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104021.6A HK1125624A1 (en) 2006-01-16 2009-04-30 Mutilin derivatives adn their use as pharmaceutical

Country Status (18)

Country Link
US (1) US7816389B2 (de)
EP (3) EP1808431A1 (de)
JP (2) JP5489467B2 (de)
KR (1) KR101434683B1 (de)
CN (1) CN101379027B (de)
AT (1) ATE502917T1 (de)
BR (1) BRPI0707117B8 (de)
CA (1) CA2635950C (de)
DE (1) DE602007013306D1 (de)
DK (1) DK1838665T3 (de)
EA (1) EA019579B1 (de)
ES (1) ES2363806T3 (de)
HK (1) HK1125624A1 (de)
IL (1) IL192756A (de)
NO (1) NO341298B1 (de)
PL (1) PL1838665T3 (de)
TW (1) TWI428316B (de)
WO (1) WO2007079515A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1808431A1 (de) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin Derivate und ihre Verwendung als Arzneimittel
EP2014640A1 (de) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin-Derivate
WO2015110481A1 (en) * 2014-01-22 2015-07-30 Nabriva Therapeutics Ag 12-epi-pleuromutilins
CN104803911B (zh) * 2014-01-23 2018-01-05 中国科学院上海药物研究所 一类截短侧耳素化合物、其药物组合物、合成方法与用途
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN109666009B (zh) * 2018-11-02 2023-02-03 华南农业大学 一种以2-氨基苯巯醇为连接基团截短侧耳素衍生物制备方法和用途
EP4135681A1 (de) * 2020-04-17 2023-02-22 Nabriva Therapeutics GMBH Neue therapeutische verwendung von pleuromutilinen
US20230174509A1 (en) * 2020-04-17 2023-06-08 Nabriva Therapeutics GmbH Therapeutic use of pleuromutilins
CN111689914B (zh) * 2020-06-18 2021-09-24 华南农业大学 一种具有1,2,4-三唑席夫碱的截短侧耳素衍生物及制备与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979423A (en) * 1969-07-25 1976-09-07 Biochemie Gesellschaft M.B.H. 14-Desoxy-14-tosyloxyacetoxy-mutilin
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
CH560180A5 (en) * 1971-10-05 1975-03-27 Sandoz Ag Pleuromutilin derivs - with antibacterial activity
DE2966635D1 (en) * 1979-01-12 1984-03-08 Sandoz Ag New pleuromutilin derivatives, their production and pharmaceutical compositions containing them
JPS5594359A (en) * 1979-01-12 1980-07-17 Sandoz Ag Novel pleuromutilin derivatives*their manufacture and use
JP3054875B2 (ja) * 1995-02-13 2000-06-19 株式会社小松製作所 プラズマトーチ
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
WO2000027790A1 (en) * 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
AU2003257493A1 (en) 2002-07-24 2004-02-16 Sandoz Ag Pleuromutilin derivatives as antimicrobbials
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
US7790767B2 (en) 2005-06-27 2010-09-07 Nabriva Therapeutics Forschungs Gmbh Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
GB0515995D0 (en) 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
EP1808431A1 (de) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin Derivate und ihre Verwendung als Arzneimittel
EP1972618A1 (de) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben

Also Published As

Publication number Publication date
DE602007013306D1 (de) 2011-05-05
EP2266955A1 (de) 2010-12-29
IL192756A (en) 2015-10-29
DK1838665T3 (da) 2011-07-11
EA019579B1 (ru) 2014-04-30
EP2266955B1 (de) 2017-07-26
NO341298B1 (no) 2017-10-02
EP1838665B1 (de) 2011-03-23
EA200870171A1 (ru) 2009-02-27
CA2635950A1 (en) 2007-07-19
TW200736205A (en) 2007-10-01
IL192756A0 (en) 2009-02-11
BRPI0707117B8 (pt) 2021-05-25
WO2007079515A1 (en) 2007-07-19
CN101379027B (zh) 2014-09-24
US7816389B2 (en) 2010-10-19
BRPI0707117A2 (pt) 2011-04-19
JP2009531278A (ja) 2009-09-03
PL1838665T3 (pl) 2011-09-30
BRPI0707117B1 (pt) 2020-08-04
KR101434683B1 (ko) 2014-08-26
ES2363806T3 (es) 2011-08-17
EP1838665A1 (de) 2007-10-03
US20080287442A1 (en) 2008-11-20
NO20083409L (no) 2008-09-18
TWI428316B (zh) 2014-03-01
CN101379027A (zh) 2009-03-04
ATE502917T1 (de) 2011-04-15
JP5489467B2 (ja) 2014-05-14
JP2013136583A (ja) 2013-07-11
CA2635950C (en) 2016-08-30
KR20080104273A (ko) 2008-12-02
EP1808431A1 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
HK1125624A1 (en) Mutilin derivatives adn their use as pharmaceutical
TW200800999A (en) Novel compounds
TW200745084A (en) Novel compounds
TN2009000239A1 (en) 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
AU2010246102A8 (en) Pesticidal compositions
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
ZA200801630B (en) Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group,processes for their preparation and their use as pharmaceuticals
MX2007011048A (es) Composiciones estables de peroxido organico.
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
TW200800967A (en) Benzimidazole thiophene compounds
WO2007005471A3 (en) Stable organic peroxide compositions
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
IL175134A0 (en) Pharmaceutical compositions containing statins with carrier-mediated transport
GB0508314D0 (en) Organic compounds
WO2007053819A3 (en) Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
TW200738627A (en) Trialkylsilyl-indoles
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
EP2125831A4 (de) Oxazinylisoflavonoidverbindungen, medikamente und anwendungen
MY148651A (en) Antitumoral compounds
MX2008001012A (es) Productos para el cuidado bucal.
GB0411165D0 (en) Hyaluronic acid containing pharmaceutical or veterinary compounds
WO2008064829A3 (en) Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof
UA34286U (en) Disinfectant

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240111